Drug maker Dishman Pharmaceuticals & Chemicals today said its consolidated net profit for the year ended March 31, 2009, rose by 22.13 per cent to Rs 146.19 crore, over the same period last year.
The company had a net profit of Rs 119.70 crore for the same period ended March 2008, Dishman Pharmaceuticals said in a filing to the Bombay Stock Exchange.
Total income of the company rose to Rs 1,067.12 crore for the period ended March 2009, from Rs 804.44 crore for the same period last year.
The board has declared a dividend of Rs 1.20 a piece on the face value of Rs 2 per share for the financial year 2008-09.
Dishman Infrastructure (DIL) discontinued as wholly owned subsidiary of the Company. DIL has issued further shares to others in the month of March, 2009. Hence, company’s holding in DIL has decreased from 100 per cent to one per cent.
Shares of Dishman Pharmaceuticals & Chemicals settled at Rs 145.35, up 4.49 per cent on the BSE.